BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar

Reuters03-26

March 25 (Reuters) - OpGen Inc :

* OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR

* OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN

* OPGEN INC: SETTLES OUTSTANDING LIABILITIES WITH EIB

* OPGEN: GOT INTO SECURITIES PURCHASE DEAL WITH DAVID LAZAR POST WHICH HE TO BUY 3 MILLION SHARES OF SERIES E PREFERRED STOCK AT $1.00/SHARE FOR $3 MILLION

* OPGEN INC: OLIVER SCHACHT, PHD, RESIGNED AS CEO

* OPGEN INC: WILL PAY $2 MILLION OF PROCEEDS FROM FINANCING TO SETTLE ALL OUTSTANDING DEBT OF COMPANY TO EACH OF EIB AND CURETIS

* OPGEN INC: SETTLEMENT AGREEMENT WITH EIB ALSO TERMINATED GUARANTEE AGREEMENT

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment